Iohexol 755mg (equivalent to 350mg of organic iodine) per mL; soln; preservative-free. IV administration: in adults, for angiocardiography (ventriculography, selective coronary arteriography), ...

Disruptions to the global supply chain, greatly intensified since the start of the pandemic, have affected multiple industries including the health care sector, which is currently suffering from ...

Amneal Pharmaceuticals announced that the U.S. FDA has approved its iohexol injection (300 mg Iodine/mL), the first generic version of GE Healthcare's Omnipaque, with plans to launch in the first ...

SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced positive top line results from a Phase 1 clinical trial of its internal Captisol-enabled (CE) Iohexol ...

(RTTNews) - Amneal Pharmaceuticals, Inc. (AMRX) announced that the U.S. Food and Drug Administration has approved its iohexol injection (300 mg Iodine/mL), the first generic version of GE Healthcare's ...

Iohexol is a radiographic contrast agent indicated for intrathecal, intra-arterial, intravenous, oral, rectal, intraarticular and body cavity imaging procedures. “We are very proud to introduce the ...

(RTTNews) - Amneal Pharmaceuticals Inc. (AMRX) announced that the U.S. Food and Drug Administration has approved its iohexol injection (300 mg Iodine/mL), marking the first generic version of GE ...

The contrast dye shortage, caused by COVID-19 lockdowns in China, has spurred leaders at healthcare systems across the nation to come up with innovative solutions to continue services with rationed ...

Amneal Pharmaceuticals (AMRX) just received U.S. FDA approval for its iohexol injection, paving the way for the first generic alternative to Omnipaque in a $652 million market. This milestone arrives ...

Videos shared online show anger at prolonged Covid-19 lockdowns in China’s economic capital of Shanghai, where officials are trying to solve issues including food shortages while doubling down on the ...